order
nidoviral
current
compris
four
familiesth
coronavirida
arterivirida
ronivirida
mesonivirida
span
across
wide
rang
host
includ
mammalian
avian
reptil
fish
invertebr
speci
http
talkictvonlineorgtaxonomi
within
order
coronavirus
arterivirus
studi
detail
due
societ
econom
impact
famili
member
unusu
featur
pathogenesi
complex
molecular
biolog
latter
includ
larg
larg
polycistron
positivestrand
rna
genom
size
rang
kb
arterivirus
kb
mesonivirus
kb
roniand
coronavirus
gorbalenya
et
al
nga
et
al
bestknown
member
arteriviru
famili
porcin
reproduct
respiratori
syndrom
viru
prrsv
equin
arter
viru
eav
coronavirus
cov
classifi
two
subfamili
torovirina
coronavirina
latter
subdivid
genera
alpha
beta
gamma
deltacoronaviru
mammalian
cov
alphaor
betacoronavirus
genera
includ
four
establish
human
coronavirus
hcov
zoonot
coronavirus
caus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
vijay
perlman
relat
virus
bat
hu
et
al
li
et
al
camel
sabir
et
al
thu
far
gammaand
deltacoronavirus
discov
mostli
avian
speci
woo
et
al
past
year
nidoviru
research
driven
forward
particular
emerg
two
lifethreaten
cov
human
betacoronavirus
sarscov
merscov
like
origin
bat
introduc
zoonot
transfer
intermedi
host
civet
cat
dromedari
camel
sarscov
merscov
respect
ge
et
al
hu
et
al
menacheri
et
al
note
presenc
neutral
antibodi
camel
suggest
merscov
relat
virus
may
present
reservoir
decad
hu
et
al
shortliv
sarscov
outbreak
result
report
case
lead
death
affect
countri
http
wwwwhointcsrsarsen
emerg
march
merscov
caus
laboratoryconfirm
human
infect
least
death
http
wwwwhointemergenciesmerscoven
clinic
present
sarscov
merscov
rang
asymptomat
mild
symptom
acut
respiratori
diseas
case
sar
origin
describ
atyp
pneumonia
accompani
fever
sever
respiratori
distress
hui
et
al
sarscov
merscov
outbreak
greatli
augment
interest
cov
famili
although
human
cov
alreadi
known
sinc
identifi
two
virus
known
caus
mild
respiratori
diseas
rhinovirus
lead
caus
common
cold
case
review
wat
associ
respiratori
diseas
review
pyrc
et
al
potenti
impact
nidovirus
veterinari
pathogen
exemplifi
porcin
epidem
diarrhea
coronaviru
pedv
also
arteriviru
prrsv
continu
caus
major
econom
loss
swine
industri
worldwid
holtkamp
et
al
lin
et
al
likewis
roniviru
infect
done
signific
damag
asian
shrimp
farm
industri
flegel
outbreak
threat
addit
emerg
zoonot
nidovirus
combin
lack
effect
antivir
strategi
highlight
import
advanc
knowledg
replic
member
divers
viru
order
interact
host
conserv
genom
organ
express
strategi
nidovirus
includ
translat
two
larg
replicas
open
read
frame
orf
genom
rna
yield
replicas
polyprotein
pp
follow
ribosom
frameshift
ctermin
extend
two
polyprotein
proteolyt
process
multipl
intern
proteas
liber
case
arteriand
coronavirus
least
nonstructur
protein
nsp
among
nsp
subunit
contain
rnadepend
rnapolymeras
helicas
function
key
player
enzym
complex
respons
viral
rna
synthesi
togeth
recruit
host
cell
protein
nidoviru
nsp
form
membraneassoci
replic
transcript
complex
gosert
et
al
hagemeij
et
al
pedersen
et
al
van
hemert
et
al
van
hemert
et
al
local
network
virusinduc
structur
typic
includ
doublemembran
vesicl
perinuclear
region
infect
cell
review
de
wild
et
al
romerobrey
bartenschlag
van
der
hoeven
et
al
nest
set
subgenom
sg
mrna
produc
express
structur
accessori
protein
encod
downstream
nidoviru
replicas
gene
pasternak
et
al
sawicki
et
al
snijder
et
al
sola
et
al
despit
common
featur
virus
order
nidoviral
variou
nidoviru
taxa
differ
strikingli
type
number
size
structur
protein
also
explain
observ
variat
virion
structur
morpholog
recent
outbreak
emerg
nidovirus
inspir
extens
studi
epidemiolog
pathogenesi
underlin
import
develop
prophylact
therapeut
option
includ
vaccin
drug
target
either
viral
function
host
factor
recruit
support
nidoviru
replic
context
inhibit
rang
rna
virus
cyclophilin
cyp
inhibitor
hopkin
gallay
prompt
sever
research
team
investig
impact
nidoviru
replic
mainli
coronavirus
lesser
extentfor
arterivirus
first
describ
key
featur
member
cyp
famili
summar
current
knowledg
regard
involv
nidoviru
replic
includ
antinidovir
effect
cyclosporin
csa
best
known
cyp
inhibitor
borel
et
al
handschumach
et
al
sever
nonimmunosuppress
analog
final
current
knowledg
involv
cyp
replic
rna
viral
pathogen
summar
illustr
wide
varieti
mechan
common
host
factor
involv
support
viral
replic
peptidylprolyl
isomeras
ppias
compris
immunophilin
superfamili
cyp
protein
fkbp
famili
belong
parvulin
protein
famili
schien
fischer
cyp
fkbp
ubiquit
eukaryot
prokaryot
protein
famili
initi
identifi
basi
abil
bind
immunosuppress
drug
csa
handschumach
et
al
rapamycin
respect
parvulin
initi
discov
cytoplasm
e
coli
rahfeld
et
al
smallest
protein
known
ppias
activ
activ
essenti
catalyz
cistran
isomer
peptid
bond
upstream
prolin
residu
ratelimit
step
protein
fold
lang
et
al
schmid
identif
first
protein
ppias
activ
fischer
et
al
coincid
purif
bovin
thymocyt
cellular
protein
high
affin
immunosuppress
csa
cyclosporinbind
protein
cypa
handschumach
et
al
five
year
later
discov
protein
one
fischer
et
al
takahashi
et
al
cyp
involv
wide
rang
cellular
process
includ
protein
fold
protein
traffick
cell
signal
naoumov
despit
fact
member
ppias
superfamili
share
enzymat
activ
protein
sequenc
structur
differ
enorm
three
famili
barik
davi
et
al
hane
human
genom
current
believ
encod
cyclophilin
fkbp
three
parvulin
gray
et
al
cyclophilin
identifi
rang
organ
includ
mammal
plant
insect
fungi
bacteria
barik
wang
heitman
cyp
catalyz
cistran
isomer
prolinepreced
peptid
bond
fact
vitro
ppias
activ
demonstr
seven
human
cyp
davi
et
al
cyp
like
cypa
consist
sole
ppias
domain
cyp
domain
flank
addit
sequenc
modular
domain
control
subcellular
local
andor
thought
specif
cellular
function
barik
schienefisch
despit
fact
cyp
implic
rang
cellular
process
function
mani
cyp
unknown
also
proven
difficult
identifi
natur
substrat
ppias
activ
review
hopkin
gallay
besid
role
specif
cellular
function
review
naoumov
cypa
cypb
cypd
shown
also
function
replic
certain
group
rna
virus
briefli
summar
cellular
function
cyp
cytosol
cypa
also
refer
peptidylprolyl
isomeras
ppia
one
abund
protein
cytoplasm
total
protein
content
express
tissu
hard
et
al
ryffel
et
al
cytosol
cypa
play
role
broad
rang
cellular
function
like
facilit
protein
fold
protein
traffick
tcell
activ
cell
signal
review
naoumov
nigro
et
al
although
cypa
normal
intracellular
protein
inflammatori
stimuli
like
infect
hypoxia
oxid
stress
elicit
cypa
secret
via
vesicular
transport
mechan
depend
rho
kinas
activ
review
bukrinski
cypa
prove
nonessenti
cell
growth
deplet
cypa
cell
ppia
knockout
mice
affect
surviv
andor
growth
kinet
chatterji
et
al
colgan
et
al
de
wild
et
al
cypb
essenti
consist
ppias
domain
equip
cleavabl
ntermin
signal
sequenc
target
protein
lumen
endoplasm
reticulum
er
price
et
al
spik
et
al
ntermin
truncat
cypb
secret
respons
inflammatori
stimuli
although
mechan
cypb
cleav
current
unclear
review
bukrinski
addit
bind
csa
csabind
site
cypb
induc
releas
cypb
er
via
secretori
pathway
hypothes
bind
csa
interfer
function
interact
cypb
erassoci
protein
normal
retain
cypb
erassoci
fearon
et
al
price
et
al
mitochondri
target
cypd
regul
mitochondri
permeabl
transit
pore
mptp
control
ca
transport
mitochondrion
cytosol
upon
sensit
calcium
overload
oxid
stress
cypd
bind
mptp
induc
open
pore
releas
ca
process
ultim
lead
necrosi
elrod
molkentin
rasola
bernardi
necroptosi
program
form
necrosi
depend
cypd
linkermann
green
csamedi
cypd
inhibit
cypd
knockout
studi
cell
cultur
shown
prevent
necrosi
cypd
mice
resist
necrot
bain
et
al
nakagawa
et
al
necroptot
cell
death
review
linkermann
green
immunosuppress
properti
csa
discov
revolution
field
organ
transplant
reduc
risk
organ
reject
review
tedesco
haragsim
csa
isol
soil
fungu
tolypcladium
inflatum
lipophil
neutral
cyclic
endecapeptid
borel
et
al
tacrolimu
isol
streptomyc
tsukubaensi
function
structur
relat
csa
goto
et
al
immunosuppress
properti
csa
depend
complex
format
cyp
respect
turn
complex
sequest
inhibit
calcineurin
serin
threonin
protein
phosphatas
key
player
cell
activ
liu
et
al
interact
calcineurin
inhibit
phosphatas
activ
latter
enzym
prevent
nuclear
transloc
substrat
nuclear
factor
activ
cell
nfat
consequ
express
immun
gene
like
liu
et
al
manner
csa
suppress
activ
cytotox
helper
cell
ho
et
al
crabtre
review
martinezmartinez
redondo
drug
prove
suitabl
immunosuppress
agent
due
absenc
toxic
commonli
associ
fungusderiv
immunosuppress
pharmaceut
subsequ
csa
also
revolution
treatment
autoimmun
diseas
rheumatoid
arthriti
crohn
diseas
vernal
keratoconjunct
well
variou
dermatolog
diseas
review
hopkin
gallay
csa
shown
inhibit
replic
varieti
dna
rna
virus
cell
cultur
see
also
chapter
context
antivir
therapi
immunosuppress
compound
like
csa
would
obvious
undesir
address
issu
varieti
csa
analog
bind
cyp
without
induc
immunosuppress
engin
secondgener
cyp
inhibitor
includ
alisporivir
alv
landrieu
et
al
paeshuys
et
al
ciechomska
et
al
hopkin
et
al
compound
modifi
abolish
affin
calcineurin
increas
affin
cyp
result
nonimmunosuppress
csa
analog
potent
inhibitor
interact
cyp
viral
protein
administr
longer
lead
inhibit
nfat
signal
calcineurin
phosphatas
activ
inhibit
therefor
drug
becom
critic
tool
studi
cyp
function
cellular
signal
pathway
andor
interact
cyp
relev
viral
replic
discuss
review
also
csa
analog
explor
antivir
drug
review
frausto
et
al
hopkin
gallay
variou
laboratori
shown
cell
cultur
replic
member
differ
cov
genera
inhibit
csa
treatment
lowmicromolar
level
csa
inhibit
replic
alphacoronavirus
transmiss
gastroenter
viru
tgev
felin
coronaviru
fcov
pedv
de
wild
et
al
kim
lee
pfefferl
et
al
tanaka
et
al
betacoronavirus
mous
hepat
viru
mhv
sarscov
merscov
de
wild
et
al
de
wild
et
al
pfefferl
et
al
collect
report
establish
broadspectrum
anticoronaviru
activ
csa
cell
culturebas
infect
model
complet
overview
nidovirus
known
inhibit
treatment
csa
andor
analog
see
tabl
coronaviru
infect
cell
cultur
also
inhibit
nonimmunosuppress
csa
analog
ec
valu
similar
csa
treatment
alv
led
twoto
fivelog
reduct
merscov
sarscov
progeni
titer
ec
valu
rang
de
wild
et
al
addit
similar
lowmicromolar
concentr
alv
csa
analog
effect
block
infect
carbajolozoya
et
al
notabl
cov
variabl
antivir
effect
observ
differ
cell
type
includ
cell
variou
vero
cell
subtyp
eg
antivir
effect
alv
sarscov
less
pronounc
cell
anoth
vero
cell
subclon
de
wild
et
al
reason
variat
antivir
effect
poorli
understood
may
includ
variat
drug
uptak
cyp
express
level
andor
overal
kinet
viru
replic
particular
cell
line
unfortun
alv
treatment
protect
mice
challeng
infect
mouseadapt
sarscov
highlight
inhibit
cell
cultur
infect
model
necessarili
translat
antivir
effect
vivo
de
wild
et
al
failur
could
taken
first
sign
cyp
inhibitor
may
use
clinic
treatment
cov
infect
clear
howev
conclus
first
need
corrobor
studi
also
includ
compound
coronaviru
nidoviru
model
might
rigor
establish
whether
current
use
cyp
inhibitor
worth
pursu
either
directli
lead
develop
hostdirect
antivir
drug
furthermor
develop
nonimmunosuppress
cyp
inhibitor
increas
potenc
solubl
drug
plasma
level
may
enhanc
antivir
activ
vivo
case
use
cyp
inhibitor
fundament
research
may
still
help
uncov
put
role
cyp
replic
cov
nidovirus
discuss
also
summari
put
role
cyp
nidoviru
replic
depict
fig
inhibitori
effect
treatment
csa
analog
see
suggest
role
one
cyp
host
factor
cov
replic
seven
year
first
report
inhibit
nidoviru
replic
cyp
inhibitor
luo
et
al
alreadi
suggest
cypa
interact
partner
sarscov
nucleocapsid
n
protein
use
surfac
plasmon
reson
measur
bind
affin
purifi
sarscov
n
protein
cypa
followup
studi
coimmunoprecipit
purifi
cypa
sarscov
n
protein
confirm
interact
two
protein
chen
et
al
use
similar
coimmunoprecipit
approach
cypa
also
shown
bind
cellular
present
plasma
membran
postul
complex
could
promot
sarscov
entri
chen
et
al
although
format
tabl
overview
effect
cyp
inhibitor
cyp
report
involv
nidoviru
replic
tripartit
protein
complex
demonstr
moreov
conceptu
difficulti
viru
entri
put
virionassoci
cypan
protein
complex
would
physic
separ
viral
envelop
consequ
difficult
envisag
interact
two
protein
use
massspectrometrybas
approach
neuman
et
al
confirm
presenc
cypa
sarscov
virion
although
function
propos
virionassoci
cypa
yeast
twohybrid
screen
identifi
potenti
interact
sarscov
sever
cyclophilin
cypa
cypb
cyph
cypg
protein
pfefferl
et
al
subsequ
import
cypa
host
factor
cov
replic
substanti
use
knockdown
knockout
cypa
express
achiev
use
varieti
approach
cell
shrnamedi
knockdown
cypa
mrna
express
normal
level
report
nearli
complet
block
replic
carbajolozoya
et
al
reduc
luciferas
express
von
brunn
et
al
cypaor
cypbknockout
felin
cell
result
nearcomplet
block
fcov
replic
interestingli
parent
cell
shrnamedi
knockdown
cypa
cypb
margin
reduc
fcov
replic
suggest
rel
small
amount
cypa
cypb
may
suffic
support
normal
level
fcov
replic
transient
overexpress
ppiasedefect
cypa
cypb
mutant
parent
cell
still
express
endogen
cypa
cypb
slightli
reduc
replic
suggest
ppias
activ
cypa
cypb
relev
fcov
replic
tanaka
et
al
import
cypa
highlight
infect
experi
use
cell
transient
express
cypa
variant
deriv
nonsynonym
singlenucleotid
polymorph
snp
contain
ppia
gene
replic
reduc
cell
express
differ
cypa
variant
display
reduc
stabil
von
brunn
et
al
involv
cypa
host
factor
coronaviru
replic
analyz
use
merscov
infect
cypaknockout
cell
gener
via
technolog
cell
compar
control
cell
reduct
merscov
titer
observ
de
wild
et
al
interestingli
replic
unchang
compar
parent
cell
result
appear
odd
studi
summar
cypa
deplet
led
reduct
luciferas
express
von
brunn
et
al
explan
contradictori
result
may
includ
use
wildtyp
versu
report
geneexpress
virus
differ
readout
viru
replic
use
instead
cell
sarscov
role
cypa
andor
cyp
infect
remain
unclear
sirnamedi
cypa
deplet
de
wild
et
al
shrnamedi
deplet
cypa
vero
cell
remain
cypa
mrna
level
de
wild
et
al
unpublish
observ
lead
reduct
sarscov
replic
howev
sinc
low
level
cypa
may
suffic
facilit
normal
replic
coronavirus
describ
fcov
depend
sarscov
cypa
cyp
requir
gener
gene
knockout
cell
line
permiss
sarscov
infect
cypd
report
play
role
pedv
infect
cypd
part
mitochondri
permeabil
transit
pore
involv
caspaseindepend
cell
death
induc
pedv
favreau
et
al
kim
lee
event
inhibit
csa
upon
infect
differenti
cell
proapoptot
protein
bax
reloc
mitochondria
may
interact
cypd
like
csa
treatment
shrnamedi
knockdown
cypd
protect
differenti
cell
program
cell
death
suggest
cypd
involv
program
cell
death
like
necroptosi
cell
favreau
et
al
role
cov
infect
cyp
gener
cypa
particular
remain
elus
although
cyp
differ
cellular
local
function
see
chapter
conceiv
cyp
substitut
cypa
host
factor
coronaviru
replic
one
candid
erassoci
cypb
may
close
proxim
site
coronaviru
replic
also
associ
erderiv
membran
structur
howev
note
cypb
locat
lumen
er
cypb
may
therefor
physic
separ
replic
complex
cytosol
side
er
membran
nevertheless
cypacypb
doubleknockout
cell
line
would
prevent
one
cyp
substitut
may
shed
light
import
cyp
cov
replic
pfefferl
et
al
show
sarscov
bind
cyp
fkbp
also
influenc
nfatregul
gene
activ
fig
activ
block
csa
treatment
pfefferl
et
al
author
show
cell
cultur
sarscov
infect
poor
activ
nfat
signal
presenc
nfat
activ
phorbol
pma
ionomycin
sarscov
infect
upregul
nfatdepend
gene
express
compar
cell
treat
pma
ionomycin
import
nfat
signal
pathway
coronaviru
replic
investig
use
drug
inde
replic
sarscov
ec
respect
found
inhibit
log
reduct
viru
yield
dose
carbajolozoya
et
al
howev
contrast
broadspectrum
inhibitori
effect
csa
replic
coronavirus
tgev
ibv
fcov
affect
treatment
cell
cultur
tanaka
et
al
von
brunn
et
al
work
tanaka
et
al
implic
member
third
group
protein
ppias
activ
parvulin
cov
infect
fig
fkbp
inhibitor
block
fcov
replic
felin
cell
chemic
inhibit
dipentamethylen
thiuram
monosulfid
dtm
reduc
approxim
cell
fcov
replic
margin
affect
shown
import
mediat
cell
cycl
progress
lin
et
al
also
implic
provir
factor
hcv
infect
lim
et
al
watashi
et
al
deplet
led
reduct
hcv
replic
could
compens
transient
express
wildtyp
express
ppiasedefect
mutant
lim
et
al
involv
infect
distinct
role
hcv
replic
infect
induc
phosphoryl
turn
reduc
express
virion
associ
known
restrict
factor
watashi
et
al
moment
role
investig
fcov
whether
protein
gener
role
cov
infect
remain
investig
research
role
cyp
cyp
inhibitor
nidoviru
infect
extend
arteriviru
famili
line
inhibitori
effect
csa
treatment
cov
replic
cell
cultur
replic
arterivirus
eav
prrsv
found
inhibit
presenc
lowmicromolar
concentr
csa
anoth
nonimmunosuppress
csa
analog
interestingli
ec
valu
replic
eav
sensit
among
nidovirus
test
far
de
wild
et
al
suggest
eav
depend
strongli
cyp
replic
drug
prevent
viral
protein
express
arterivirusinfect
cell
ah
de
wild
et
al
virolog
reduc
viru
yield
log
de
wild
et
al
likewis
compound
block
vitro
rna
synthesi
assay
use
semipurifi
replic
structur
eavinfect
cell
point
toward
direct
inhibit
viral
rna
synthesi
csaresist
eav
mutant
select
serial
passag
presenc
compound
mutat
primarili
map
multispan
membraneassoci
subunit
viral
replicas
addit
vitro
rna
synthesi
activ
replic
complex
prepar
cell
infect
csaresist
eav
inde
insensit
csa
treatment
de
wild
et
al
manuscript
prepar
role
arteriviru
replic
poorli
understood
protein
suggest
play
role
finetun
convers
intracellular
membran
viral
replic
organel
van
der
hoeven
et
al
note
previous
postul
cypa
associ
eav
replic
organel
protein
cosedi
membraneassoci
eav
replic
complex
densiti
gradient
pretreat
sampl
csa
prevent
cosediment
presenc
cypa
ppias
activ
de
wild
et
al
manuscript
prepar
inde
shown
pivot
eav
replic
de
wild
et
al
knockout
cypa
express
result
reduct
eav
progeni
yield
replic
affect
much
less
strongli
cell
express
reduc
level
cypa
de
wild
et
al
de
wild
et
al
highlight
small
amount
cypa
may
suffic
support
effici
nidoviru
replic
see
collect
observ
indic
cypa
essenti
host
factor
bind
arteriviru
replic
organel
support
rna
synthesi
fig
inhibit
eav
rna
synthesi
csa
treatment
suggest
cypa
direct
role
process
rather
involv
format
replic
organel
contrast
report
hcv
chatterji
et
al
madan
et
al
see
import
cyp
rna
viru
replic
antivir
effect
cyp
inhibitor
document
quit
extens
chapter
briefli
summar
relev
find
regard
involv
cyp
replic
group
rna
virus
respect
human
immunodefici
viru
hepat
c
viru
hcv
influenza
viru
studi
detail
data
also
summar
previous
number
excel
review
baugh
gallay
campbel
hope
hopkin
gallay
liu
et
al
red
inhibitori
effect
infect
indic
induc
chemic
inhibitor
proteininhibitor
complex
proteinprotein
complex
see
chapter
chapter
detail
abbrevi
grna
positivestrand
genom
nidoviru
rna
polyprotein
polyprotein
rc
replic
complex
caln
calcineurin
csa
cyclosporin
cyp
cyclophilin
fkbp
bind
protein
peptidylprolyl
cistran
isomeras
nimainteract
cypi
cyclophilin
inhibitor
mptp
mitochondri
permeabl
transit
pore
nsp
nonstructur
protein
dtm
dipentamethylen
thiuram
monosulfid
p
phosphat
nfat
nuclear
factor
activ
tcell
ah
de
wild
et
al
virolog
infect
cypa
play
role
disassembl
stage
capsid
core
nuclear
import
reversetranscrib
genom
howev
molecular
detail
process
remain
poorli
understood
cypa
bind
capsid
core
interact
capsid
protein
ca
monom
enclos
viral
genom
gener
believ
way
cypa
ensur
genom
follow
entri
reversetranscrib
cdna
insid
capsid
core
reach
nucleu
sens
immun
system
review
campbel
hope
hopkin
gallay
csa
shown
inhibit
replic
human
cell
disrupt
cacypa
interact
billich
et
al
frank
luban
hydrophob
pocket
cypa
interact
ca
catalyz
cistran
isomer
peptid
bond
induc
conform
chang
ca
bosco
et
al
frank
et
al
gambl
et
al
thali
et
al
event
thought
trigger
disassembl
capsid
core
although
avail
data
conflict
research
inde
show
cypa
bind
ca
destabil
capsid
core
frick
et
al
other
found
cypa
stabil
capsid
core
shah
et
al
third
studi
suggest
discrep
may
caus
concentr
differ
low
amount
cypa
stabil
core
high
level
lead
disassembl
interact
ca
may
also
prevent
ca
bind
restrict
factor
presum
shown
restrict
retroviru
replic
oldworld
monkey
cell
tower
et
al
review
hopkin
luban
hypothesi
strengthen
observ
newworld
owl
monkey
cell
express
fusion
protein
spri
domain
replac
cypa
cypa
domain
fusion
protein
direct
domain
capsid
core
restrict
replic
also
contrast
inhibit
infect
csa
human
cell
treatment
owl
monkey
cell
cyp
inhibitor
enhanc
replic
increas
replic
effici
presum
mediat
block
interact
ca
nisol
et
al
sayah
et
al
report
potent
inhibit
hcv
replic
hepatocyt
csa
nakagawa
et
al
watashi
et
al
cypa
identifi
essenti
host
factor
hcv
replic
chatterji
et
al
kaul
et
al
nakagawa
et
al
yang
et
al
import
substanti
observ
hcv
infect
restrict
cypaknockout
mice
dorner
et
al
subsequ
sever
key
observ
made
studi
aim
elucid
mechan
cypa
regul
hcv
replic
excel
review
see
hopkin
gallay
lin
gallay
inactiv
cypa
ppias
activ
mutagenesi
reveal
enzymat
activ
pivot
effici
hcv
replic
cell
cultur
chatterji
et
al
liu
et
al
ii
cypa
interact
directli
hcv
replic
complex
bind
multipl
prolin
residu
locat
domain
ii
iii
determin
cypa
bind
substrat
ppias
activ
fernand
et
al
foster
et
al
hanoul
et
al
shirota
et
al
mutat
assum
contribut
resist
facilit
cypaindepend
replic
hcv
coelmont
et
al
iv
grow
evid
interact
directli
link
rnasynthes
activ
hcv
replic
complex
mere
involv
format
stabil
hcvinduc
membran
web
replic
organel
replic
complex
associ
chatterji
et
al
madan
et
al
efficaci
csa
nonimmunosuppress
analog
alv
block
hcv
infect
cell
cultur
model
ciesek
et
al
coelmont
et
al
hopkin
et
al
ishii
et
al
et
al
paeshuys
et
al
watashi
et
al
ultim
led
evalu
drug
clinic
trial
alv
reach
phase
iii
clinic
trial
overal
trial
show
alv
combin
directact
antiviralscan
contribut
ifnfre
pangenotyp
hcv
therapi
although
date
none
cyp
inhibitor
approv
hcv
treatment
outcom
trial
review
detail
membreno
et
al
naoumov
besid
hcv
csa
also
inhibit
replic
flavivirus
establish
west
nile
viru
wnv
dengu
viru
denv
yellow
fever
viru
yfv
qing
et
al
latter
studi
show
essenti
role
cypa
ppias
activ
denv
wnv
replic
case
wnv
japanes
enceph
viru
jev
inhibitori
effect
csa
attribut
block
function
interact
qing
et
al
cypa
shown
interact
yfv
infect
vidotto
et
al
interestingli
jev
seem
depend
mainli
enzymat
activ
cypb
replic
mostli
via
interact
kambara
et
al
contrast
cypa
provir
role
eg
hcv
replic
cypa
act
restrict
factor
influenza
viru
replic
review
liu
et
al
multifunct
matrix
protein
involv
variou
stage
viru
replic
cycl
cypa
interact
protein
acceler
degrad
ubiquitinproteasomedepend
pathway
liu
et
al
liu
et
al
overexpress
cypa
transgen
mice
reduc
influenza
viru
replic
furthermor
influenza
viru
infect
macrophag
isol
cypaoverexpress
mice
show
upregul
host
antivir
gene
compar
macrophag
wildtyp
mice
upregul
may
like
contribut
resist
influenza
viru
infect
mice
interestingli
cyp
inhibitor
csa
cyp
inhibitor
exhibit
broadspectrum
influenza
viru
b
antivir
activ
hamamoto
et
al
et
al
vivo
studi
show
surviv
csatreat
mice
infect
lethal
influenza
viru
dose
schiltknecht
ada
furthermor
liu
et
al
claim
csa
limit
influenza
viru
replic
cypadepend
independ
manner
csa
increas
cypa
bind
affin
time
decreas
nuclear
import
influenza
viru
genom
cypadeplet
cell
liu
et
al
effici
viral
replic
depend
concert
interact
viral
protein
host
cell
factor
cyp
demonstr
play
multifacet
role
replic
rang
rna
virus
investig
detail
hcv
key
role
cyp
viral
life
cycl
demonstr
wide
varieti
ah
de
wild
et
al
virolog
techniqu
includ
use
cell
mice
partial
complet
deplet
specif
cyp
complement
studi
ppiasedefici
cyp
protein
mutant
viral
protein
unabl
interact
cyp
use
non
immunosuppress
cyp
inhibitor
analysi
drugresist
virus
virus
cypa
believ
main
cyp
involv
viru
replic
specif
mode
action
viru
replic
appear
differ
greatli
among
virus
instanc
cypa
believ
bind
ca
ensur
reversetranscrib
genom
reach
nucleu
sens
immun
system
hcv
infect
cypa
involv
gener
virusinduc
replic
organel
andor
proper
fold
hcv
protein
interact
viral
rna
viral
protein
current
data
other
laboratori
suggest
divers
role
cyp
especi
cypa
nidoviru
replic
exampl
cypa
hypothes
incorpor
sarscov
virion
neuman
et
al
may
suggestfor
reason
fulli
understood
momentthat
cypa
chaperon
function
enhanc
infect
sarscov
pfefferl
et
al
report
varieti
cyp
includ
cypa
abl
modul
nfat
signal
sarscovinfect
cell
interact
sarscov
howev
relev
result
context
viral
replic
cycl
current
unclear
nonimmunosuppress
analog
interfer
nfat
signal
inhibit
sarscov
replic
case
arteriviru
eav
cypa
play
role
viral
rna
synthesi
albeit
exact
function
poorli
understood
whether
cypa
also
involv
rna
synthesi
activ
nidovirus
warrant
investig
eg
test
cyp
inhibitor
activ
isol
replic
complex
nidovirusinfect
cell
case
mechanist
detail
interact
nidovir
protein
cyp
remain
resolv
may
also
provid
basi
new
therapeut
approach
nido
virus
recruit
cyp
host
factor
replic
